Why this NHS hospital trust asks all its clinical pharmacists to become independent prescribers An NHS hospital trust in north-east England now insists that its clinical pharmacists hold an independent prescribing qualification. Stephen Robinson finds out why.…
Global agency seeks US$1bn to support people caught up in humanitarian crisesThe World Health Organization wants to raise more than US$1bn to meet the health needs of millions caught up in Syrian and other crises.…
Clinical research: Regulatory uncertainty hits drug trials in India An avalanche of reforms to rules governing the conduct of clinical trials in India has led to an exodus of drug companies and research organisations.…
Testing applied knowledge in the registration assessment is a welcome move Changes to the pre-registration assessment will ensure trainees can apply their knowledge in practice using a wide range of resources.…
Number of smokers using NHS services to quit halves, report finds The number of smokers who quit smoking through the NHS Stop Smoking Service will halve in England in 2014–2015, according to a UCL report.…
US FDA approves drug that prolongs survival in rare paediatric cancer The US Food and Drug Administration has approved dinutuximab as part of first-line therapy for a rare childhood cancer, neuroblastoma. …
FDA grants priority approval for new antifungalIsavuconazonium sulfate, an antifungal developed by Astellas, has been given priority approval by the US Food and Drug Administration to treat serious infections.…
A pharmacist’s journey through the Ebola epidemicPharmacist Claire Liew is currently volunteering at an Ebola treatment centre in Sierra Leone. She explains how the disease has affected everyday life.…
How the pharmaceutical industry is contributing to antimicrobial resistance Through poor practices, the pharmaceutical industry is adding to the problem of antimicrobial resistance instead of helping to solve it.…
Skin cancer drug fast tracked under early access to medicines schemeA drug for advanced skin cancer, pembrolizumab, has become the first medicine to be fast tracked to patients under the UK’s early access to medicines scheme.…